Inovio Pharmaceuticals

Inovio has secured funding from the U.S Department of Defense to expedite the development and production of its Cellectra 3PSP Smart Devices for the administration of the COVID-19 vaccine. INO stock is up.

In the last three months, INO has pulled in more than 181% returns. For 2020, Inovio (INO) investors have seen 233.33% returns.

Inovio (INO) stock was jumped 8% yesterday, is in the green now after the company released its fiscal Q1 earnings report, while it is working on a coronavirus vaccine.